Hostname: page-component-586b7cd67f-vdxz6 Total loading time: 0 Render date: 2024-11-30T20:08:25.201Z Has data issue: false hasContentIssue false

Health-Related Quality of Life after Intensive Care Unit Discharge: A Comparison between 2 Standard Antibiotic Regimens

Published online by Cambridge University Press:  02 January 2015

Mamoon A. Aldeyab
Affiliation:
Clinical and Practice Research Group, School of Pharmacy, Queen's University Belfast, Northern Ireland, United Kingdom
Mary P. Kearney
Affiliation:
United Hospitals Trust, Antrim, Northern Ireland, United Kingdom
Michael G. Scott
Affiliation:
United Hospitals Trust, Antrim, Northern Ireland, United Kingdom
Joanne Hanley
Affiliation:
United Hospitals Trust, Antrim, Northern Ireland, United Kingdom
James C. McElnay*
Affiliation:
Clinical and Practice Research Group, School of Pharmacy, Queen's University Belfast, Northern Ireland, United Kingdom
*
Clinical and Practice Research Group, School of Pharmacy, Queen's University Belfast, Belfast BT9 7BL, UK ([email protected])
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2009

References

1.Kollef, MH, Fraser, VJ. Antibiotic resistance in the intensive care unit. Ann Intern Med 2001;134:298314.Google Scholar
2.Carlet, J, Ben Ali, A, Chalfine, A. Epidemiology and control of antibiotic resistance in the intensive care unit. Curr Opin Infect Dis 2004;17:309316.CrossRefGoogle ScholarPubMed
3.Mcgowan, JE Jr. Antimicrobial resistance in hospital organisms and its relation to use antibiotic. Rev Infect Dis 1983;5:10331048.CrossRefGoogle Scholar
4.Muller, AA, Mauny, F, Bertin, M, et al.Relationship between spread of methicillin-resistant Staphylococcus aureus and antimicrobial use in a French university hospital. Clin Infect Dis 2003;36:971978.Google Scholar
5.Monnet, DL, Mackenzie, FM, Lopez-Lozano, JM, et al.Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000. Emerg Infect Dis 2004;10:14321441.CrossRefGoogle ScholarPubMed
6.Aldeyab, MA, Monnet, DL, López-Lozano, JM, et al.Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis. J Antimicrob Chemother 2008;62:593600.CrossRefGoogle ScholarPubMed
7.Aldeyab, MA, Hughes, CM, Kearney, MP, et al.Comparison of the effect of ciprofloxacin and Tazocin on the incidence of meticillin-resistant Staphylococcus aureus (MRSA) in an intensive care unit. Int J Antimicrob Agents 2008;32:499504.CrossRefGoogle Scholar
8.EuroQol Group. EuroQol: a new facility for the measurement of health related quality of life. Health Policy 1990;16:199208.CrossRefGoogle Scholar
9.Dolan, P. Modeling valuations for EuroQol health states. Med Care 1997;35:10951108.Google Scholar